Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31370
Abstract: The prognosis is poor for patients who have relapsedârefractory acute myelogenous leukemia (AML). Most published reports analyzed results from therapies in firstâsalvage AML or in studies that were conducted before 2000. Several novel agents and…
read more here.
Keywords:
since 2000;
results second;
myelogenous leukemia;
second salvage ... See more keywords